Circulating Cancer Biomarkers
Cancer is among the major public health problems worldwide, representing the leading cause of morbidity and mortality in industrialized countries [...]
Main Authors: | Anna Lokshin, Robert C. Bast, Karin Rodland |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-02-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/4/802 |
Similar Items
-
Reply to Comment on “Osteopontin, Macrophage Migration Inhibitory Factor and Anti-Interleukin-8 Autoantibodies Complement CA125 for Detection of Early Stage Ovarian Cancer” <i>Cancers</i> 2019, <i>11</i>, 596: Markers for Early Detection of Ovarian Cancer
by: Jing Guo, et al.
Published: (2019-09-01) -
Circulating miRNAs as Tumor Biomarkers: A Preface to the Special Issue
by: Athina N. Markou
Published: (2020-12-01) -
Emerging Circulating Biomarkers in Atherosclerosis: From Molecular Mechanisms to Therapeutic Strategies
by: Giuseppe Mandraffino, et al.
Published: (2022-06-01) -
Letter to the Editor: “Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy”
by: Chiara Nicolazzo, et al.
Published: (2017-06-01) -
Xeno-miRs and Circulating miRNAs as Novel Biomarkers in Certain Diseases
by: Gülsüm Deveci, et al.
Published: (2022-12-01)